Allied Market Research

Hadron Therapy Market Forecast, 2017-2023

Increase in incidence of cancer, rise in healthcare expenditure, fuels the growth of the global hadron therapy market.


Portland, OR -- (SBWIRE) -- 08/28/2017 -- Ionizing radiations are used to treat cancer and the procedure is known as radiation therapy. When the ionizing radiations are made up of charged particles such as protons, carbon, and other ions, then radiation therapy is called as Hadron Therapy.

Early buyers will receive 20% customization on this report.

These charged particles have unique physical and radiobiological properties such as less diffusion that allows them to penetrate the tissues and destroy the cancerous cells with maximum energy. Hadron therapy destroys the cancerous cells by damaging their DNA. This therapy is more advantageous than the traditional approach as it delivers long-term protection against cancer, has minimal side effects, and avails treatment to more cancer types.

There are many factors, such as increase in incidence of cancer, rise in healthcare expenditure, increased access to medical insurance, and technological advancements in cancer treatment therapies that fuel the growth of the global hadron therapy market.

However, the factors such as lack of awareness about hadron therapy, and less number of therapy providers are anticipated to inhibit the growth of the market. Also, the high product developmental cost is expected to impede the growth of the market.

Request for Sample @

The market is segmented based on type, application, end-users, and geography. By type, the market is categorized into electron beam, proton beam, neutron beam, carbon ion beam, alpha particle beam, and beta particle beam. By application, it is classified into pediatric cancer, bone and soft tissue cancer, prostate cancer, lung cancer, liver cancer, eye cancer, head & neck cancer, and other applications. By end users, it is divided into hospitals, cancer research centers, and clinics. By geography, it is studied across North America, Europe, Asia Pacific, and LAMEA.